Clinical Trial Update: Efficacy Study of IL-21 to Treat Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 efficacy study of IL-21 for metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• IL-21 (interleukin-21)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Cancer, Malignant Melanoma | Phase 2 | Status: COMPLETED